Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Phio Pharmaceuticals Corp...

    NASDAQ: PHIO · Real-Time Price · USD
    2.40
    -0.08 (-3.23%)
    At close: Jun 17, 2025, 3:59 PM
    2.34
    -2.50%
    After-hours: Jun 17, 2025, 04:41 PM EDT

    Phio Pharmaceuticals Statistics

    Share Statistics

    Phio Pharmaceuticals has 4.8M shares outstanding. The number of shares has increased by 4.03% in one year.

    Shares Outstanding

    n/a
    		 4.8M

    Shares Change (YoY)

    n/a
    		 4.03%

    Shares Change (QoQ)

    n/a
    		 175.73%

    Owned by Institutions (%)

    n/a
    		 4.22%

    Shares Floating

    n/a
    		 4.73M

    Failed to Deliver (FTD) Shares

    n/a
    		 68,756

    FTD / Avg. Volume

    n/a
    		 2.1%

    Short Selling Information

    The latest short interest is 226.84K, so 4.73% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 226.84K

    Short % of Shares Out

    n/a
    		 4.73%

    Short % of Float

    n/a
    		 4.73%

    Short Ratio (days to cover)

    n/a
    		 1.07

    Valuation Ratios

    The PE ratio is -1.98 and the forward PE ratio is -2.72. Phio Pharmaceuticals's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.98

    Forward PE

    n/a
    		 -2.72

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 3

    P/FCF Ratio

    n/a
    		 -1.99

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Phio Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.65, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 5.65

    Quick Ratio

    n/a
    		 5.65

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -31.98

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,430,000

    Employee Count

    n/a
    		 5

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -62.52% in the last 52 weeks. The beta is 0.85, so Phio Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.85

    52-Week Price Change

    n/a
    		 -62.52%

    50-Day Moving Average

    n/a
    		 2.03

    200-Day Moving Average

    n/a
    		 2.31

    Relative Strength Index (RSI)

    n/a
    		 57.45

    Average Volume (20 Days)

    n/a
    		 3,271,022

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -7.39M

    Net Income

    n/a
    		 -7.15M

    EBITDA

    n/a
    		 -7.12M

    EBIT

    n/a
    		 -6.92M

    Earnings Per Share (EPS)

    n/a
    		 -0.91
    Full Income Statement

    Balance Sheet

    The company has 5.38M in cash and 0 in debt, giving a net cash position of 5.38M.

    Cash & Cash Equivalents

    n/a
    		 5.38M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -146.36M

    Total Assets

    n/a
    		 13.44M

    Working Capital

    n/a
    		 12.17M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -7.11M and capital expenditures -1K, giving a free cash flow of -7.11M.

    Operating Cash Flow

    n/a
    		 -7.11M

    Capital Expenditures

    n/a
    		 -1K

    Free Cash Flow

    n/a
    		 -7.11M

    FCF Per Share

    n/a
    		 -0.9
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PHIO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PHIO is $14, which is 466.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $14

    Price Target Difference

    n/a
    		 466.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 5, 2024. It was a backward split with a ratio of 1:9.

    Last Split Date

    n/a
    		 Jul 5, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:9

    Scores

    Altman Z-Score

    n/a
    		 -10.97

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist